SUBSCRIBE
2 minutes
Edinburgh-based PhaSER Biomedical (PhaSER) has received a grant totalling $2.3 million (around £1.81m) to continue its work in accelerating drug discovery and development from the Bill & Melinda Gates Foundation.
